Abstract
Dipeptidyl Peptidase IV (DPIV, also known as DPIV or CD26) has a unique enzymatic activity, cleaving dipeptides from peptides and proteins carrying proline in their penultimate position, a feature which protects peptides from being digested by nonspecific proteases (Yaron and Naider, 1993). DPIV is associated with the plasma membrane of a variety of cells, including the venous portion of capillary endothelial cells (Mrazkowa et al 1986), hepatocytes (Kreisel et al 1984), enterocytes (Darmoul et al 1994) and cells of the renal glomeruli and proximal tubuli (Barth et al 1974). Expression of DPIV defines a higher degree of cell maturation and differentiation (Darmoul et al 1992). Organ-specific functions and regulatory circuits appear to have impact on DPIV expression, such as a proline-rich diet in the intestinal epithelium Suzuki et al 1993), γ-interferon in kidney (Stefanowicz et al 1993) and antigenic Schmitz et al 1996) or mitogenic (Plana et al 1991) stimulation of T lymphocytes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arck, P.C., Ferrick, D.A., Steele-Norwood, D., Egan, P.J., Croitoru, K., Carding, S.R., etal 1999, Murine T cell determination of pregnancy outcome. Cell Immunol. 196: 71–79.
Arck, P.C., Merali, F.S., Manuel, J., Chaouat, G., and Clark, DA, 1995, Stress-triggered abortion: inhibition of protective suppression and promotion of tumor necrosis factoralpha (TNF-alpha) release as a mechanism triggering resorptions in mice. Am. J. Reprod. Immunol 33: 74–80.
Arck, P.C., Merali, F.S., Stanisz, A.M., Stead, R.H., Chaouat, G., Manuel, J., et al 1995, Stress-induced murine abortion associated with substance P-dependent alteration in cytokines in maternal uterine decidua. Biol. Reprod. 53: 814–819.
Barth, A., Schulz, H., and Neubert, K., 1974, Untersuchungen und Charakterisierung der Dipeptidylpeptidase IV. Acta biologica et medica germanica 32: 157–174.
Campbell, R.M., Strieker, P., Miller, R., Bongers, J., Liu, W., Lambros, T., et al, 1994, Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences. Peptides 15(3): 489–495.
Clark, D.A., Chaouat, G., Arck, P.C, Mittruecker, H.W., Levy, G.A., 1998, Cytokinedependent abortion in CBA x DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase. J. Immunol. 160: 545–549.
Darmoul, D., Voisin, T., Couvineau, A., Rouyer Fessard, C., Salomon, R., Wang, Y., et al, 1994, Regional expression of epithelial dipeptidyl peptidase IV in the human intestines. Biochem. Biophys. Res. Commun. 203: 1224–1229.
Darmoul, D., Lacasa, M., Baricault, L., Marguet, D., Sapin, C., Trotot, P., et al, 1992, Dipeptidyl peptidase IV (CD 26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. Cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation. J. Biol. Chem. 267: 4824–4833.
De Meester, I., Korom, S., Van Damme, J., and Scharpe, S., 1999, CD26, let it cut or cut it down. Immunol. Today 20: 367.27.
Demuth, H.-U., 1990, Recent developments in the irreversible inhibition of serine and cysteine proteases. J. Enzyme Inhibition 3: 249–278.
Demuth, H.-U., and Heins, J., On the catalytic Mechanism of Dipeptidyl Peptidase IV, 1995,in Dipeptidyl Peptidase IV (B. Fleischer, Ed.) R.G. Landes, Biomedical Publishers,Georgetown, 1–37.
Hartel-Schenk, S., Minnifield, N., Reutter, W., Hanski, C., Bauer, C., andMone, D.J., 1991,Distribution of glycosyltransferases among Golgi apparatus subtractions from liver and hepatomas of the rat. Biochim. Biophys. Acta 1115: 108–22.
Hildebrandt, M., Arck, P., Demuth, H.U., Kruber, S., Reutter, W., and Klapp, B.F., 2001,Inhibition of Dipeptidyl peptidase IV (DP IV, CD26) activity abrogates stress-induced,cytokine-mediated murine abortions. Scand. J. Immunol. 53: 449–454.
Hildebrandt, M., Reutter, W., and Gitlin, J.D. 1991, Tissue-specific regulation of dipeptidyl peptidase IV expression during development. Biochem. J. 277(2): 331–334.
Hopsu-Havu, V.K., and Glenner, G.G. 1966, A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-ß-naphthylamide. Histochemie 7: 197–200.
Kähne, T., Lendeckel, U., Wrenger, S., Neubert, K., Ansorge, S., and Reinhold, D. 1999,Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth. Int.J.Mol.Med. 4: 3–15.
Kähne, T., Neubert, K., and Ansorge, S., 1995, Enzymatic activity of DP IV/CD 26 is involved in PMA-induced hyperphosphorylation of p561ck. Immunol. Lett. 189–193.
Korom, S., De Meester, I., Stadlbauer, T.H., Chandraker, A., Schaub, M., Sayegh, M.H.,Belyaev, A., Haemers, A., Scharpe, S., and Kupiec Weglinski, J.W., 1997, Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. Transplantation 63: 1495.
Kreisel, W., Hildebrandt, H., Mössner, W., Tauber, R., and Reutter, W., 1993,Oligosaccharide reprocessing and recycling of a cell surface glycoprotein in cultured rat hepatocytes. Biol. Chem. Hoppe Seyler 374: 255–263.
Kreisel, W., Reutter, W., and Gerok, W., 1984, Modification of the intramolecular heterogeneous turnover of terminal carbohydrates of dipeptidylaminopeptidase IV isolated from rat-liver plasma membrane during liver regeneration. Eur. J. Biochem. 138: 435–8.
Krishnan, L., Guilbert, L.J., Wegmann, T.G., Belosevic, M., and Mosmann, T.R., 1996, T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. Correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells. J. Immunol. 156: 653–662.
Markert, U.R., Arck, P.C., McBey, B.A., Manuel, J., Croy, B.A., Marshall, J.S., et al 1997,Stress triggered abortions are associated with alterations of granulated cells into the decidua. Am. J. Reprod. Immunol. 37: 94–100.
Masuyama,. J., Yoshio, T., Suzuki, K., Kitagawa, S., Iwamoto, M., Kamimura, T., et al, 1999,Characterization of the 4C8 antigen involved in transendothelial migration of CD26(hi)T cells after tight adhesion to human umbilical vein endothelial cell monolayers. J. Exp.Med. 189: 979–990.
Morimoto, C., and Schlossman, S.F. 1998, The structure and function of CD26 in the T-cell immune response. Immunol. Rev. 161: 55–70.
Mrazkova, O., Grim, M., and Carlson, B.M., 1986, Enzymatic heterogeneity of the capillary bed of rat skeletal muscles. Am. J. Anat. 177: 141–148.
Nausch, I., Mentlein, R., and Heymann, E., 1990, The degradation of bioactive peptides and proteins by dipeptidyl peptidase IV from human placenta. Biol Chem. Hoppe Seyler 371:1113–1118.
Pauly, R.P., Demuth, H.U., Rosche, F., Schmidt, J., White, H.A., Lynn, F., Mcintosh, C.H.S.,and Pederson, R.A., 1999, Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (DP IV; CD 26) inhibitor Ile-thiazolidide. Metabolism 48: 385–389.
Pauly, R.P., Rosche, F., Wermann, M., Mclntosh, C.H., Pederson, R.A., and Demuth, H.U.,1996, Investigation of GIP1.42 and GLP-17.36 Degradation in vitro by Dipeptidyl Peptidase IV (DP IV) using Matrix-Assisted Laser Desorption/Ionization - Time of Flight Mass Spectrometry (MALDI-TOF MS): a Novel Kinetic Approach. J. Biol Chem. 271: 23222–23229.
Pederson,R.A., White, H.A., Schlenzig, D., Pauly, R.P., Mcintosh, C.H.S., and Demuth, till, 1998, Improved glucose tolerance in zucker fatty rats treated by oral administration of the dipeptidyl peptidase IV inhibitor isoleucyl thiazolidide. Diabetes 47: 1253–1258.
Plana, M., Vinas, O., De la Calle Martin, O., Lozano, F., Ingles Esteve, J., Romero, M., et al, 1991, Induction of interleukin 2 (IL 2) and interferon-gamma and enhancement of IL 2 receptor expression by a CD26 monoclonal antibody. Eur. J. Immunol. 21: 1085–1088.
Reinhold, D., Bank, U., Bühling, F., Lendeckel, U., Faust, J., Neubert, K., and Ansorge, S.,1997, Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factorbeta 1 in PWM-stimulated PBMC and T cells. Immunology 91:354.
Schmitz, T., Underwood, R., Khiroya, R., Bachovchin, W.W., and Huber, B,T., 1996 Potentiation of the immune response in HTV-1+ individuals. J. Clin. Invest 97: 1545–1549.
Stefanovic, V., Ardaillou, N., Vlahovic, P., Placier, S., Ronco, P., and Ardaillou, R., 1993,Interferon-gamma induces dipeptidylpeptidase IV expression in human glomerular epithelial cells. Immunology 80: 465–470.
Suzuki, Y., Erickson, R.H., Sedlmayer, A., Chang, S.K., Ikehara, Y., and Kim, Y.S., 1993,Dietary regulation of rat intestinal angiotensin-converting enzyme and dipeptidyl peptidase IV. Am. J. Physiol. 264: Gl 153–G1159.
Tanaka, T., Kameoka, J., Yaron, A., Schlossman, S.F., and Morimoto, C., 1993, The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc. Natl Acad. Sci. USA 90: 4586–90.
von Bonin, A., Steeg, C., Mittrucker, H.W., and Fleischer, B., 1997, The T-cell receptor associated zeta-chain is required but not sufficient for CD26 (dipeptidylpeptidase IV) mediated signaling. Immunol Lett. 55: 179–182.
Willheim, M., Ebner, C., Baier, K., Kern, W., Schrattbauer, K., Thien, R., et al, 1997, Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets. J. Allergy Clin. Immunol. 100: 348–355.
Xu, X., and Chong, A.S., 1995, Cross-linking of CD45 on NK cells stimulates p561ckmediated tyrosine phosphorylation and IFN-gamma production. J. Immunol. 155: 5241–5248.
Yaron, A., and Naider, F., 1993, Proline-dependent structural and biological properties of peptides and proteins. Crit. Rev. Biochem. Mol. Biol. 28: 31–81.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hildebrandt, M., Demuth, HU., Reutter, W. (2002). CD26/DPIV in Stress-induced, Cytokine-mediated Abortions. In: Langner, J., Ansorge, S. (eds) Ectopeptidases. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0619-5_12
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0619-5_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5161-0
Online ISBN: 978-1-4615-0619-5
eBook Packages: Springer Book Archive